APAC

Sparse clinical evidence hinders male infertility therapy development, report says

Male infertility can be caused by a poor lifestyle, amongst others.

Asia-Pacific ventricular assist device market surges on rising disease burden

The market is projected to reach $2.81b by 2031, growing annually at 8.44%.

How can hospitals adapt as care shifts beyond their walls?

China, India, and Japan are driving growth in the telehealth market.

Asia now accounts for 49% of all global cancer cases

In Singapore, cancer accounts for 26.2% of all fatalities.

APAC hearing implants market to inch up 1% as Sonova builds Singapore hub

GlobalData expects the market to grow at 1% CAGR until 2026.

Tech solutions key to APAC healthcare yet outcomes still shaped by inequality—Deloitte

Half of APAC’s population is expected to live on less than $8.30 per day in 2025.

Asia Pacific care providers favour agentic AI over generative systems

However, this transition requires regulatory frameworks, IDC says.

Menarini wins 3 accolades at Healthcare Asia Pharma Awards 2026

It received awards for its child-friendly allergy innovation, reshaping Herpes Zoster care, and Menarini Connect.

Chronic pain surge boosts spinal cord stimulation market to $4.8b by 2032

This also comes as patients shift away from opioid-based treatments.

Implant demand fuels medical stampings market surge to $34.48b by 2034

Asia-Pacific emerges as the fastest growing market as production capacity expands.

Pressure ulcers market to reach $5.6b by 2031 as ageing populations drive demand

By region, Asia-Pacific emerged as the fastest-growing market, with a 5.3% CAGR.

Healthcare digital signage market projected to reach $20.85b by 2034

It is driven by ongoing digital transformation in healthcare.

CENGILD G.I Medical Centre lauded at Healthcare Asia Awards 2026

The centre was recognised for advancing endoscopic innovation and multidisciplinary integration.

Healthcare payer market to nearly double by 2034 on outsourcing boom

Core insurance functions move to vendors as payers scale under regulatory pressure.

Tick-borne allergy drives Alpha-Gal market towards 8.5% expansion by 2034

Asia-Pacific outpaces regions as allergy awareness and healthcare systems scale up.